A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome (Odyssey Outcomes)
The purpose of this study is to learn more about a study drug that may help prevent future cardiovascular events (such as heart attack or stroke). The study drug may help reduce LDL (bad) cholesterol.
Acute coronary syndrome (ACS)
Includes but not limited to:
-Men and women age 18+
-Subjects with high cholesterol who experienced acute coronary syndrome (ACS) in the last 12 months.
-Subjects also at risk to experience another cardiovascular event (such as heart attack or stroke) in the future.
40 - 99
Healthy Volunteers Needed
Duration of Participation
Susan Dean, RN, BSN, MPH, CCRC
To reimburse for time and travel, subjects will be paid $100.00 for each study visit to OHSU.